🇺🇸 FDA
Patent

US 9526882

Percutaneous administration device and method for producing the same

granted A61KA61K2800/87A61K8/676

Quick answer

US patent 9526882 (Percutaneous administration device and method for producing the same) held by OPTNICS PRECISION CO., LTD. expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OPTNICS PRECISION CO., LTD.
Grant date
Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2800/87, A61K8/676, A61K9/703, A61K9/7084